Daniel M. Huse
Impact in
-
- Blood Pressure and Hypertension Studies
- Acute Myocardial Infarction Research
-
- Diabetes, Cardiovascular Risks, and Lipoproteins
Papers in
-
- Pharmaceutical Practices and Patient Outcomes 4
- Co-authors
- Mason W. RussellStuart C. HartzRalph B. D’AgostinoGerry OsterR. Curtis EllisonHalit SilbershatzPeter W.F. WilsonGregory Lenhart
- Journals
- Annals of Pharmacotherapy (5 papers)Value in Health (4 papers)PharmacoEconomics (2 papers)The American Journal of Medicine (2 papers)Current Medical Research and Opinion (2 papers)
- Partner nations
- United StatesCanadaHungary
In The Last Decade
Daniel M. Huse
43 papers receiving 1.9k citations
Peers
Comparison fields: 5 of 128
- Cardiology and Cardiovascular Medicine 454
- Endocrinology, Diabetes and Metabolism 323
- Internal Medicine 64
- Economics and Econometrics 462
- Family Practice 36
Countries citing papers authored by Daniel M. Huse
This map shows the geographic impact of Daniel M. Huse's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Daniel M. Huse with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Daniel M. Huse more than expected).
Fields of papers citing papers by Daniel M. Huse
This network shows the impact of papers produced by Daniel M. Huse. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Daniel M. Huse. The network helps show where Daniel M. Huse may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Daniel M. Huse, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2011 | 40 | |
| 2 | 2006 | 18 | |
| 3 | 2006 | 8 | |
| 4 | 2006 | 9 | |
| 5 | Impact of leflunomide versus biologic agents on the costs of care for rheumatoid arthritis in a managed care population. | 2002 | 19 |
| 6 | Use of managed care claims data in the risk assessment of venous thromboembolism in outpatients. | 2002 | 25 |
| 7 | 2002 | 1 | |
| 8 | Cost effectiveness of HMG-CoA reductase inhibition in Canada. | 2001 | 26 |
| 9 | 2000 | 95 | |
| 10 | 1998 | 1 | |
| 11 | 1998 | 62 | |
| 12 | 1996 | 19 | |
| 13 | 1993 | 24 | |
| 14 | 1992 | 2 | |
| 15 | 1992 | 6 | |
| 16 | 1990 | 46 | |
| 17 | 1990 | 37 | |
| 18 | 1989 | 4 | |
| 19 | 1989 | 30 | |
| 20 | Accident- and injury-related health-care utilization among benzodiazepine users and nonusers. | 1987 | 35 |
About Daniel M. Huse
Daniel M. Huse is a scholar working on Geriatrics and Gerontology, Gastroenterology, Internal Medicine, Applied Microbiology and Biotechnology and Pharmacology, having authored 45 papers that have together received 2.0k indexed citations. Recurring topics across this work include Health Systems, Economic Evaluations, Quality of Life (10 papers), Lipoproteins and Cardiovascular Health (6 papers), Pharmaceutical Economics and Policy (6 papers), Blood Pressure and Hypertension Studies (4 papers), Pharmaceutical Practices and Patient Outcomes (4 papers), Asthma and respiratory diseases (4 papers), Acute Myocardial Infarction Research (3 papers) and Rheumatoid Arthritis Research and Therapies (3 papers). The work is most often cited by research in Cardiology and Cardiovascular Medicine (454 citations), Endocrinology, Diabetes and Metabolism (323 citations), Internal Medicine (64 citations), Economics and Econometrics (462 citations) and Family Practice (36 citations). Daniel M. Huse has collaborated with scholars based in United States, Canada and Hungary. Frequent co-authors include Mason W. Russell, Stuart C. Hartz, Ralph B. D’Agostino, Gerry Oster, R. Curtis Ellison, Halit Silbershatz, Peter W.F. Wilson, Gregory Lenhart, Lucinda Orsini and Jane Castelli‐Haley. Their work appears in journals such as Annals of Pharmacotherapy, Value in Health, PharmacoEconomics, The American Journal of Medicine and Current Medical Research and Opinion.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.